BlackRock Inc. (NYSE:BLK) is cashing in some of its chips in a clutch of medical device companies at the same time as it put more skin into Wright Medical Group Inc. (NSDQ:WMGI), according to regulatory filings.
Varian Medical Systems
DePuy gets FDA clearance for new hip amid lawsuit over old hip | Regulatory Roundup
Amid lawsuits concerning its Pinnacle metal-on-metal hip implant, Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics won U.S. Food & Drug Administration clearance for its next-generation Pinnacle ceramic-on-metal hip implant.
Ceramic-on-metal is a novel combination in the hip implant market, having undergone two-year controlled, randomized, multicenter, non-inferiority clinical study and laboratory testing as part of the clearance process.
Quintiles aims to restructure debt with $2 billion in credit | Funding roundup
Quintiles is resuming its plans to raise more than $2 billion in bank financing.
The Durham, N.C.-based, contract research organization is planning to enter into a new $2.2 billion credit facility, with proceeds from the borrowed funding being used to refinance $1.7 billion in existing debt, including an offer to buy $525 million of 9.5 percent outstanding senior notes that are due in 2014.
Varian profits bounce 13 percent on increased sales | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
FDA clears Biomet’s hip implant | Regulatory roundup
Biomet Inc. received FDA 510(k) clearance for its new hip replacement device.
Warsaw, Ind.-based company said its Active Articulation E1 dual mobility hip system is an implant option for orthopedic surgeons performing hip replacement surgery.
Caliper and HistoRx collaborate on biomarkers | Distribution roundup
Here’s a roundup of companies announcing new distribution deals.
Retina Implant closes $18 million round | Funding roundup
Sub-retinal prosthesis developer Retina Implant AG raised $18 million in venture capital funding.
The company’s sub-retinal implant is comprised of a microchip that’s inserted into the eye to restore vision for people suffering from retinitis pigmentosa, a retinal degeneration disorder.
Varian Med shares higher following 3.5-million share buyback last week
Varian Medical Systems Inc. (NYSE:VAR) late last week inked a deal with Bank of America to buy back about $280 million worth of its common stock, reducing the amount of outstanding shares by almost 3 percent.
Fluidigm, Kips Bay close IPOs | Funding roundup
Microfluidics company Fluidigm Corp. (NSDQ:FLDM) and medical device developer Kips Bay Medical Inc. (NSDQ:KIPS) both went public late last week.
San Francisco-based Fluidigm priced its offering of about 5.6 million shares of its common stock at $13.50 per share — the bottom of its range — and raised $75 million.
Toshiba wins $36 million contract from Uncle Sam
The Dept. of Defense awarded Toshiba America Medical Systems Inc. a $36 million medical imaging equipment supply deal.
The 12-month contract with the DoD’s Defense Logistics Agency calls for the Tustin, Calif.-based unit of Toshiba Corp. (TYO:6502) to supply radiology systems, subsystems and components to the Army, Navy, Air Force, Marine Corps and federal civilian agencies, according to the Defense Dept.’s website.
Earnings roundup: Hill-Rom profits leap 78 percent
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
